WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH). The Grant will help to fund experiments to demonstrate the feasibility of using the Company’s patented Pressure Cycling Technology (PCT) in the development of a novel method for the extraction of clinically important protein biomarkers, sub-cellular molecular complexes, and organelles from cells and tissues. The SBIR Grant is for a total of $149,470 over six months.
